BeiGene
ONC
#733
Rank
NZ$44.40 B
Marketcap
$382.06
Share price
-0.76%
Change (1 day)
71.80%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeiGene (ONC)

EPS in 2024 (TTM): -$10.44

According to BeiGene 's latest financial reports the company's current EPS (TTM) is -$10.40. .

EPS history for BeiGene from 2015 to 2024

Annual EPS

Year EPS Change
2024-$10.40
2022-$32.5028.21%
2021-$25.35-19.96%
2020-$31.6720.81%
2019-$26.2231.52%
2018-$19.93417.57%
2017-$3.85-37.16%
2016-$6.13158.95%
2015-$2.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.67-83.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.45-95.67%๐Ÿ‡บ๐Ÿ‡ธ USA